Clinical trials: Post COVID-19 Cognitive Impairment
COVID-19, Sars-CoV-2 Infection
Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection
Recent studies suggest cognitive, emotional and behavioural impairments occur in patients after SARS-CoV-2 infection. Problems with memory, attention, information processing and executive functions are particularly prevalent in…
- Trial name
- NCT05143320
- Where
- Italy
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- Ospedale Generale Di Zona Moriggia-Pelascini
Cognitive Impairment, Post-Acute Sequelae of SARS-CoV-2 Infection
Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCS
After almost 2 years of pandemic, the consequences of the post-COVID syndrome, or PASC (Post Acute-Sequelae of Sars-CoV-2), have become a major challenge in the management of affected patients, generating costs for health…
- Conditions
- Cognitive Impairment, Post-Acute Sequelae of SARS-CoV-2 Infection, COVID-19
- Trial name
- PASC (NCT05389592)
- Testing
- Active tDCS and cognitive training
- Where
- Brazil
- Volunteers
- 60 people
- Sponsor
- University of Sao Paulo
COVID-19, Quality of Life
Long-term Quality of Life and Prognostic Factors in Severe COVID-19 Patients and Their Relatives
This is a prospective cohort study with multicenter retrospective data collection (CHR Metz-Thionville, Hôpital Mercy and Hôpital Bel Air).
- Conditions
- COVID-19, Quality of Life, Posttraumatic Stress Disorder, Cognitive Impairment
- Trial name
- QUALICOVID (NCT05520047)
- Testing
- COVID19-severe Patient, family of COVID19-severe Patient
- Where
- France
- Volunteers
- 800 people
- Sponsor
- Centre Hospitalier Régional Metz-Thionville
Covid19, Post-COVID / Long-COVID
Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae
Weeks and months after they have seemingly recovered from COVID-19, many patients continue to suffer from major long-term effects.
- Trial name
- NCT04881305
- Testing
- questionnaires and neuropsychological assessment
- Where
- Israel
- Volunteers
- 70 people
- Sponsor
- Rabin Medical Center
Long COVID, Post-Acute COVID-19 Syndrome
A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
Purpose: To decrease symptom burden, improve cognitive function, improve endurance, and decrease fatigue in subjects with post-acute sequelae of COVID-19 (PASC) or "long-hauler" COVID using amantadine.
- Trial name
- NCT06234462
- Testing
- Amantadine, Physical, Occupational, Speech Therapy, Provider Counseling
- Where
- United States
- Sponsor
- University of Texas Southwestern Medical Center
COVID 19, Oxydative Stress
Oxidative Stress and Cognitive Dysfunction After COVID-19
This observational cohort study will investigate the association between oxidative stress biomarkers and post-COVID-19 cognitive impairment.
- Conditions
- COVID 19, Oxydative Stress, Cognitive Impairments
- Trial name
- NCT07029048
- Testing
- Standard Post-COVID Rehabilitation Program
- Where
- Kazakhstan
- Volunteers
- 45 people
- Sponsor
- Karaganda Medical University
Long COVID
tDCS in the Management of Post-COVID Disorders
Different physical and mental morbidities such as pain, fatigue, depressed mood and cognitive impairment can be triggered by coronavirus infection.
- Trial name
- tDCS (NCT06074848)
- Testing
- Transcranial Direct Current Stimulation (tDCS), Motor Training, Cognitive Training
- Where
- 2 sites in Brazil
- Volunteers
- 48 people
- Sponsor
- Universidade Federal de Pernambuco
Working Memory, Post-covid-19
Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment
In genome-wide association studies we identified potassium channels to be genetically linked to performance and neural activity of working memory in healthy humans.
- Trial name
- FamC (NCT05274477)
- Testing
- Fampridine SR
- Where
- Switzerland
- Volunteers
- 8 people
- Sponsor
- Prof. Dominique de Quervain, MD
Post COVID-19 Cognitive Impairment
A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Some people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as post COVID-19 conditions (PCC) or long COVID1.
- Trial name
- NCT05857124
- Testing
- Vielight Neuro RX Gamma active device
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- Vielight Inc.
ME/CFS, ME/CFS Following EBV-associated Infectious Mononucleosis
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
The purpose of this study is to compare two approaches to cognitive rehabilitation in adults with post-viral cognitive syndrome, which resulted in brain fog.
- Conditions
- ME/CFS, ME/CFS Following EBV-associated Infectious Mononucleosis, ME/CFS Following COVID-19, Chronic Fatigue
- Trial name
- NCT07523113
- Testing
- Processing Speed Training, In-session Instrumental Activities of Daily Living Training, Transfer Package
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of Alabama at Birmingham